Hematopoietic stem cell transplantation in B- and T-cell lymphoma [PDF]
, 2013 Huijgens, P.C. [Promotor]Mulder, C.J.J. [Promotor]Dongen, G.A.M.S.
Visser, O.
core +2 more sources
Radioimmunoterapy: a promising therapeutic approach to treat ovarian carcinoma [PDF]
, 2015 O cancro do ovário é a neoplasia ginecológica com maior índice de mortalidade entre a população do sexo feminino apesar dos consideráveis progressos verificados no seu tratamento.
Oliveira, Maria Cristina +1 more
core +2 more sources
Radioimmunotherapy of Lymphoma
Archive of Oncology, 2012 Radiolabeled monoclonal antibodies for the treatment of follicular low-grade non-Hodgkin’s lymphoma have been available for several years in the United States and more recently throughout Europe. Since their introduction to treatment of refractory or relapsed patients, they have been evaluated for efficacy earlier in the course of the disease including
openaire +3 more sources
Targeting Metabolic Reprogramming in Tumor: From Mechanisms to Precision Immunotherapies
MedComm – Oncology, Volume 4, Issue 4, December 2025.Cancer metabolic reprogramming is a key hallmark of tumorigenesis and antitumor immunity. It boosts tumor progression by enhancing cancer cell fitness in hostile microenvironments and facilitates immune evasion by evading natural and therapy‐driven antitumor immune responses.
Tong Zhang, Ping Gao, Linchong Sun
wiley +1 more source
Blood and Lymphatic Cancer: Targets and Therapy, 2023 Jing Wang,1 Firas Baidoun,2 Han W Tun,2 Muhamad Alhaj Moustafa2 1Department of Internal Medicine, Mayo Clinic Florida, Jacksonville, FL, 32224, USA; 2Division of Hematology and Medical Oncology, Mayo Clinic Florida, Jacksonville, FL, 32224 ...
Wang J +3 more
doaj
Radiolabeled Antibody Fragment for Preparation of (177Lu-DOTA)m-PAMAM G3.0-F(ab\u27)2 Trastuzumab as a Radiopharmaceutical for Cancer Therapy [PDF]
, 2017 Several radiolabeled monoclonal antibodies (mAbs) have been used as radioimmunotherapy (RIT) agents for cancer therapy. The use of mAbs as RIT agents is due to their ability to carry effectors, in the form of radionuclides which emit alpha (α) particles,
Haryuni, R. D. (R) +3 more
core +3 more sources
Diffuse Large B‐Cell Lymphoma Combined With Paroxysmal Nocturnal Hemoglobinuria: A Rare Case Report
Clinical Case Reports, Volume 13, Issue 11, November 2025.ABSTRACT Diffuse large B‐cell lymphoma (DLBCL) is a common hematological malignancy, and some patients may present with autoimmune hemolytic anemia (AIHA). However, the coexistence of DLBCL and paroxysmal nocturnal hemoglobinuria (PNH) is rare. PNH patients may develop myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML), but lymphomas are ...
Zhen zhen Liu +5 more
wiley +1 more source
Cancer Medicine, 2019 Background Pancreatic ductal adenocarcinoma (PDAC) accounts for >90% of pancreatic malignancies, and has median survival of
Rubin Jiao +9 more
doaj +1 more source
Differentiation of irradiation and cetuximab induced skin reactions in patients with locally advanced head and neck cancer undergoing radioimmunotherapy: the HICARE protocol (Head and neck cancer: ImmunoChemo and Radiotherapy with Erbitux) – a multicenter phase IV trial [PDF]
, 2013 BACKGROUND: In order to improve the clinical outcome of patients with locally advanced squamous cell carcinoma of the head and neck (LASCCHN) not being capable to receive platinum-based chemoradiation, radiotherapy can be intensified by addition of ...
A Abdollahi +7 more
core +1 more source
Radioimmunotherapy of Infectious Diseases [PDF]
Seminars in Nuclear Medicine, 2009 The need for novel approaches to treat infectious diseases is obvious and urgent. This situation has renewed interest in the use of monoclonal antibodies (mAbs) to treat infectious diseases. During the last 5 years, radioimmunotherapy (RIT), a modality developed for cancer treatment, has been successfully adapted for the treatment of experimental ...
Ekaterina, Dadachova, Arturo, Casadevall
openaire +2 more sources